Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-331-7 | CAS number: 13749-61-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: In accordance with REACH Annex VIII (8.8.1) an assessment of toxicokinetic behavior has been conducted to the extent that can be derived from the relevant available information.
- Adequacy of study:
- key study
- Study period:
- The assessment was conducted in December 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Relevant studies were reviewed by a qualified toxicologist with a view to fulfilling the requirements of Annex VIII (8.8.1).
- Objective of study:
- toxicokinetics
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- In accordance with REACH Annex VIII (8.8.1) an assessment of toxicokinetic behaviour has been conducted to the extent that can be derived from the relevant available information. The assessment is based on the Guidance on information requirements and chemical safety assessment R.7c: Endpoint specific guidance (ECHA, May 2008)
- GLP compliance:
- no
- Remarks:
- Not relevant for assessment
- Conclusions:
- The available information suggests that absorption of the test item from the gastrointestinal tract can take place. Once absorbed in significant amounts corresponding to a subchronic oral dose of 100 mg/kg bw/day in rats, concentrations leading to slight histopathological changes in the neural tissue are achieved. However, a clear dose-dependency is lacking and there is no indication for any behavioural or functional deficits up to a subchronic dose of 350 mg/kg bw/day. There is no evidence for bioaccumulation of the test item due to its low partition co-efficient and high water solubility.
- Executive summary:
The available information suggests that the substance is readily available via the oral route. This is supported by the physico-chemical properties of the substance.
Once absorbed, the test item would not be expected to accumulate in body fat due to the low log octanol:water partition coefficient (log Pow). Due to the small molecular size and water solubility, penetration of the intact dermis will occur to a limited extent. Urinary excretion is considered to be the significant route for the substance.
Reference
TOXICOKINETIC BEHAVIOUR
The test item is composed as listed in IUCLID section 1.2 (composition). It is a yellow crystalline solid and the molecular weight is 127.18 g/mol. The test item is of limited volatility with a vapour pressure of 3.9 Pa at 25ºC and predicted negative explosive and oxidising properties. The test item also has been shown to have a particle size distribution of 0.165% of particles less than 100μm in diameter . In consequence inhalation based on minimal vapour pressure and large particle size is not expected to be a significant route of exposure.
The test item has a low log octanol/water partition coefficient (Log10 Pow = 0.491) and high water solubility (30.5 g/l). The available repeat dose oral with reproductive screening study in rats showed evidence of absorption and distribution. Distribution is likely to occur in blood plasma due to the solubilty of the test item.
The test item is non-mutagenic in bacteria and non-clastogenic in mammalian cells in vitro in either the absence or presence of an
auxiliary metabolising system. The substance is not classified as a dermal irritant nor a skin sensitizer.
Absorption
Results of the oral repeat dose study with reproduction / developmental toxicity screening study in rats show evidence to support the absorption of the test item. The actual molecule size and water solubility of the test item suggest that absorption across the gastro-intestinal tract would be a result of a simple diffusion process and therefore provides a route of potential absorption, following oral administration. Distribution of the test item is likely to occur as a result of simple systemic distribution in blood plasma. This may account for the perceived slight effects on the nervous system.
Limited absorption may occur via the skin due to small molecular size and the solubility of the test item.
Distribution
Systemic distribution can potentially occur following absorption from the gastrointestinal tract. This is suggested from the results of the repeted dose/reproduction screening test due to the slight microscopic sciatic nerve changes observed.
Metabolism
The results of the repeated dose/reproductive screening study did not show evidence to indicate any test item influenced hepatic metabolism. The results of the in vitro genotoxicity assays do not show any evidence that the addition of the S9 metabolising
system either enhance or diminish the genotoxic potential of the substance.
Excretion
There is no evidence to indicate the route of excretion. As the test item is highly water soluble, it is expected that this would facilitate urinary excretion.
Description of key information
The available information suggests that the substance is readily available via the oral route. This is supported by the physico-chemical properties of the substance.
Once absorbed, the test item would not be expected to accumulate in body fat due to the low log octanol:water partition coefficient (log Pow). Due to the small molecular size and water solubility, penetration of the intact dermis will occur to a limited extent. Urinary excretion is considered to be the significant route for the substance.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
TOXICOKINETIC BEHAVIOUR
The test item is composed as listed in IUCLID section 1.2 (composition). It is a yellow crystalline solid and the molecular weight is 127.18 g/mol. The test item is of limited volatility with a vapour pressure of 3.9 Pa at 25ºC and predicted negative explosive and oxidising properties. The test item also has been shown to have a particle size distribution of 0.165% of particles less than 100μm in diameter . In consequence inhalation based on minimal vapour pressure and large particle size is not expected to be a significant route of exposure.
The test item has a low log octanol/water partition coefficient (Log10Pow = 0.491) and high water solubility (30.5 g/l). The available repeat dose oral with reproductive screening study in rats showed evidence of absorption and distribution. Distribution is likely to occur in blood plasma due to the solubilty of the test item.
The test item is non-mutagenic in bacteria and non-clastogenic in mammalian cells in vitro in either the absence or presence of an
auxiliary metabolising system. The substance is not classified as a dermal irritant nor a skin sensitizer.
Absorption
Results of the oral repeat dose study with reproduction / developmental toxicity screening study in rats show evidence to support the absorption of the test item. The actual molecule size and water solubility of the test item suggest that absorption across the gastro-intestinal tract would be a result of a simple diffusion process and therefore provides a route of potential absorption, following oral administration. Distribution of the test item is likely to occur as a result of simple systemic distribution in blood plasma. This may account for the perceived slight effects on the nervous system.
Limited absorption may occur via the skin due to small molecular size and the solubility of the test item.
Distribution
Systemic distribution can potentially occur following absorption from the gastrointestinal tract. This is suggested from the results of the repeted dose/reproduction screening test due to the slight microscopic sciatic nerve changes observed.
Metabolism
The results of the repeated dose/reproductive screening study did not show evidence to indicate any test item influenced hepatic metabolism. The results of the in vitro genotoxicity assays do not show any evidence that the addition of the S9 metabolising
system either enhance or diminish the genotoxic potential of the substance.
Excretion
There is no evidence to indicate the route of excretion. As the test item is highly water soluble, it is expected that this would facilitate urinary excretion.
Conclusion
The available information suggests that absorption of the test item from the gastrointestinal tract can take place. Once absorbed in significant amounts corresponding to a subchronic oral dose of 100 mg/kg bw/day in rats, concentrations leading to slight histopathological changes in the neural tissue are achieved. However, a clear dose-dependency is lacking and there is no indication for any behavioural or functional deficits up to a subchronic dose of 350 mg/kg bw/day. There is no evidence for bioaccumulation of the test item due to its low partition co-efficient and high water solubility.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.